Compare IQIYI Inc - ADR (IQ) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IQIYI Inc - ADR vs GeneDx Holdings Corp — how do they compare? IQIYI Inc - ADR trades at $1.02 (market cap $974.67M), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: GeneDx Holdings Corp is far larger — about 2.1× IQIYI Inc - ADR's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, IQIYI Inc - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IQIYI Inc - ADR for 55 Days and GeneDx Holdings Corp for 19 Days on average.
| IQ | WGS | |
|---|---|---|
Market Cap | $974.67M | $2.02B |
Volume | 4,964,108 | 734,640 |
Sector | Media | Health |
52-Week High | $2.35 | $167.51 |
52-Week Low | $0.86 | $34.51 |
Typical Hold Time | 55 Days | 19 Days |
Enterprise Value | $2.47B | $2.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
iQIYI (IQ) trades at $1.01, down 0.49% with bearish technical signals. The company reported Q2 2026 revenue of $6.3 billion (up 1% sequentially) but posted a net loss of -$206 million for 2025. Analyst consensus is mixed with 50% buy ratings, while technical indicators show bearish momentum with neutral oscillators. Recent developments include the successful launch of AI-generated content series 'The Ferry Man' generating over RMB 8 million in revenue-sharing.
The outlook remains challenging with declining revenue trends and negative profitability, though the company's pivot to AI-driven content production offers potential cost savings. Key risks include streaming business contraction and Chinese regulatory environment. Wall Street maintains cautious optimism with 11 buy ratings but investors should monitor Q3 earnings for turnaround evidence.
GeneDx (WGS) trades at $67.73, down 1.17% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth to $454M in 2026 but faces profitability challenges with a -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth story with expanding genomic testing volumes but carries significant execution risk given negative profitability metrics. Upside potential exists if management can translate revenue growth into sustainable profits, though current cash flow trends and high valuation multiples warrant caution for risk-averse investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About IQIYI Inc - ADR
iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.
Read more on IQ →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
